Latest World News. Find every day short and brief information composed of titles and subtitles and continue reading if interested.
Martin Shkreli doesn’t have a monopoly on jacking up drug prices. Marathon Pharmaceuticals has received FDA approval for an old drug used to treat Duchenne muscular dystrophy, deflazacort, and in the process has raised the price to ridiculously high levels. You could previously import the generic medicine for about $ 1,200 per year, but it […]
Marathon Pharmaceuticals will charge $ 89,000 annually in the U.S. for a decades-old steroidal drug that was approved for U.S. sale for the first time on Thursday, a price that is as much as 70 times higher than drug’s price overseas. WSJ.com: What’s News US
